Last updated on November 2017

Wingspan® StEnt System Post MArket SurVEillance Study


Brief description of study

Wingspan® StEnt System Post MArket SurVEillance Study

Detailed Study Description

The Wingspan® Stent System with Gateway® Percutaneous Transluminal Angioplasty (PTA)

Balloon Catheter was approved in the United States (US) under a Humanitarian Device

Exemption (HDE) and received CE Mark in 2005.

This study is being conducted to fulfill Food and Drug Administration (FDA) post market safety

surveillance requirements

Clinical Study Identifier: TX8513

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Feather Wafford

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington, KY USA
  Connect »